A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer

Condition:   Prostate Cancer Interventions:   Drug: enzalutamide;   Drug: enzalutamide Placebo;   Drug: digoxin;   Drug: rosuvastatin Sponsors:   Astellas Pharma Global Development, Inc.;   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials